XML 82 R38.htm IDEA: XBRL DOCUMENT v3.19.3
Financial Information for Guarantor Subsidiaries and Non-Guarantor Subsidiaries (Tables)
9 Months Ended
Sep. 30, 2019
Financial Information for Guarantor Subsidiaries and Non-Guarantor Subsidiaries [Abstract]  
Supplemental Condensed Consolidating Balance Sheet

SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES
SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEET
As of September 30, 2019
 
SGC (Parent)
 
SGI (Issuer1)
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminating
Entries
 
Consolidated
Assets
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
194

 
$

 
$

 
$
170

 
$
(1
)
 
$
363

Restricted cash

 
1

 
37

 
8

 

 
46

Accounts receivable, net

 
105

 
193

 
338

 

 
636

Notes receivable, net

 

 
110

 
13

 

 
123

Inventories

 
53

 
114

 
103

 
(13
)
 
257

Prepaid expenses, deposits and other current assets
6

 
57

 
70

 
92

 
1

 
226

Property and equipment, net
32

 
95

 
223

 
197

 
(31
)
 
516

Operating lease right-of-use asset
1

 
24

 
32

 
50

 

 
107

Investment in subsidiaries
3,147

 
992

 
1,162

 

 
(5,301
)
 

Goodwill

 
240

 
1,897

 
1,114

 

 
3,251

Intangible assets, net
34

 
34

 
1,137

 
374

 

 
1,579

Intercompany balances

 
5,871

 
70

 

 
(5,941
)
 

Software, net
59

 
36

 
98

 
77

 

 
270

Other assets(2)
105

 
436

 
45

 
385

 
(438
)
 
533

Total assets
$
3,578

 
$
7,944

 
$
5,188

 
$
2,921

 
$
(11,724
)
 
$
7,907

Liabilities and stockholders’ (deficit) equity
 
 
 
 
 
 
 
 
 
 
 
Current portion of long-term debt
$

 
$
285

 
$
2

 
$
1

 
$

 
$
288

Other current liabilities
79

 
215

 
250

 
246

 
(33
)
 
757

Long-term debt, excluding current portion

 
8,474

 
8

 

 

 
8,482

Operating lease liabilities
1

 
20

 
27

 
43

 

 
91

Other long-term liabilities
92

 
25

 
593

 
174

 
(470
)
 
414

Intercompany balances
5,629

 

 

 
312

 
(5,941
)
 

Total SGC stockholders’ (deficit) equity
(2,223
)
 
(1,075
)
 
4,308

 
2,047

 
(5,280
)
 
(2,223
)
Noncontrolling interest

 

 

 
98

 

 
98

Total liabilities and total stockholders’ (deficit) equity
$
3,578

 
$
7,944

 
$
5,188

 
$
2,921

 
$
(11,724
)
 
$
7,907

(1) Issuer of obligations under the Subordinated Notes, the Unsecured Notes and the Secured Notes.
(2) Includes $11 million and $1 million in non-current restricted cash for Guarantor Subsidiaries and Non-Guarantor Subsidiaries, respectively.
SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES
SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEET
As of December 31, 2018
 
SGC (Parent)
 
SGI (Issuer1)
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminating
Entries
 
Consolidated
Assets
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
74

 
$
1

 
$

 
$
94

 
$
(1
)
 
$
168

Restricted cash

 
1

 
32

 
6

 

 
39

Accounts receivable, net

 
79

 
205

 
315

 

 
599

Notes receivable, net

 

 
101

 
13

 

 
114

Inventories

 
40

 
82

 
111

 
(17
)
 
216

Prepaid expenses, deposits and other current assets
6

 
63

 
92

 
72

 

 
233

Property and equipment, net
31

 
112

 
219

 
218

 
(33
)
 
547

Investment in subsidiaries
2,836

 
975

 
1,093

 

 
(4,904
)
 

Goodwill

 
240

 
1,897

 
1,143

 

 
3,280

Intangible assets, net
43

 
34

 
1,291

 
441

 

 
1,809

Intercompany balances

 
6,054

 

 

 
(6,054
)
 

Software, net
58

 
39

 
128

 
60

 

 
285

Other assets(2)
110

 
404

 
46

 
308

 
(440
)
 
428

Total assets
$
3,158

 
$
8,042

 
$
5,186

 
$
2,781

 
$
(11,449
)
 
$
7,718

Liabilities and stockholders’ (deficit) equity
 
 
 
 
 
 
 
 
 
 
 
Current portion of long-term debt
$

 
$
42

 
$

 
$
3

 
$

 
$
45

Other current liabilities
64

 
162

 
248

 
254

 
(26
)
 
702

Long-term debt, excluding current portion

 
8,991

 

 
1

 

 
8,992

Other long-term liabilities
106

 
8

 
637

 
172

 
(481
)
 
442

Intercompany balances
5,451

 

 
49

 
554

 
(6,054
)
 

Total SGC stockholders’ (deficit) equity
(2,463
)
 
(1,161
)
 
4,252

 
1,797

 
(4,888
)
 
(2,463
)
Total liabilities and total stockholders’ (deficit) equity
$
3,158

 
$
8,042

 
$
5,186

 
$
2,781

 
$
(11,449
)
 
$
7,718

(1) Issuer of obligations under the Subordinated Notes, the Unsecured Notes (other than the 2026 Unsecured Notes, which were not issued until March 2019) and the Secured Notes.
(2) Includes $12 million and $1 million in non-current restricted cash for Guarantor Subsidiaries and Non-Guarantor Subsidiaries, respectively.

Supplemental Condensed Consolidating Statement of Income
SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES
SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF
OPERATIONS AND COMPREHENSIVE (LOSS) INCOME
Three Months Ended September 30, 2019
 
SGC (Parent)
 
SGI (Issuer1)
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminating
Entries
 
Consolidated
Revenue
$

 
$
139

 
$
376

 
$
419

 
$
(79
)
 
$
855

Cost of services, cost of product sales and cost of instant products(2)

 
93

 
119

 
170

 
(65
)
 
317

SG&A
34

 
9

 
55

 
88

 
(11
)
 
175

R&D

 
1

 
22

 
24

 

 
47

D&A
16

 
8

 
99

 
44

 
(5
)
 
162

Restructuring and other

 
1

 
2

 
8

 

 
11

Operating (loss) income
(50
)
 
27

 
79

 
85

 
2

 
143

Interest expense

 
(146
)
 

 

 

 
(146
)
Gain on remeasurement of debt

 
19

 

 

 

 
19

Other income (expense), net
14

 
129

 
(117
)
 
(27
)
 

 
(1
)
Net (loss) income before equity in income of subsidiaries and income taxes
(36
)
 
29

 
(38
)
 
58

 
2

 
15

Equity in income of subsidiaries
36

 
9

 
22

 

 
(67
)
 

Income tax benefit (expense)
14

 
(8
)
 
8

 
(11
)
 

 
3

Net income (loss)
14

 
30

 
(8
)
 
47

 
(65
)
 
18

Less: Net income attributable to noncontrolling interest

 

 

 
4

 

 
4

Net income (loss) attributable to SGC
$
14

 
$
30

 
$
(8
)
 
$
43

 
$
(65
)
 
$
14

Net income (loss)
$
14

 
$
30

 
$
(8
)
 
$
47

 
$
(65
)
 
$
18

Other comprehensive (loss) income
(35
)
 
30

 
(1
)
 
(61
)

32


(35
)
Total comprehensive (loss) income
(21
)
 
60

 
(9
)
 
(14
)
 
(33
)
 
(17
)
Less: comprehensive income attributable to noncontrolling interest

 

 

 
4

 

 
4

Comprehensive (loss) income attributable to SGC
$
(21
)
 
$
60

 
$
(9
)
 
$
(18
)
 
$
(33
)
 
$
(21
)
(1) Issuer of obligations under the Subordinated Notes, the Unsecured Notes and the Secured Notes.
(2) Excludes D&A.
SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES
SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF
OPERATIONS AND COMPREHENSIVE (LOSS) INCOME
Three Months Ended September 30, 2018
 
SGC (Parent)
 
SGI (Issuer1)
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminating
Entries
 
Consolidated
Revenue
$

 
$
138

 
$
404

 
$
361

 
$
(82
)
 
$
821

Cost of services, cost of product sales and cost of instant products(2)

 
90

 
119

 
160

 
(68
)
 
301

SG&A
38

 
12

 
57

 
76

 
(13
)
 
170

R&D

 

 
21

 
29

 

 
50

D&A
11

 
9

 
106

 
45

 
(5
)
 
166

Restructuring and other
320

 
3

 
4

 
12

 

 
339

Operating (loss) income
(369
)
 
24

 
97

 
39

 
4

 
(205
)
Interest expense

 
(147
)
 

 

 

 
(147
)
Gain on remeasurement of debt

 
(4
)
 

 

 

 
(4
)
Other income (expense), net
16

 
130

 
(123
)
 
(19
)
 

 
4

Net (loss) income before equity in income of subsidiaries and income taxes
(353
)
 
3

 
(26
)
 
20

 
4

 
(352
)
Equity in income (loss) of subsidiaries

 
4

 
(10
)
 

 
6

 

Income tax benefit (expense)
1

 
(1
)
 
6

 
(6
)
 

 

Net (loss) income
$
(352
)
 
$
6

 
$
(30
)
 
$
14

 
$
10

 
$
(352
)
Other comprehensive (loss) income
(5
)
 
11

 
(10
)
 
(2
)
 
1

 
(5
)
Comprehensive (loss) income
$
(357
)
 
$
17

 
$
(40
)
 
$
12

 
$
11

 
$
(357
)
(1) Issuer of obligations under the Subordinated Notes, the Unsecured Notes (other than the 2026 Unsecured Notes, which were not issued until March 2019) and the Secured Notes.
(2) Excludes D&A.


Supplemental Condensed Consolidating Statement of Cash Flows
SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES
SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
Nine Months Ended September 30, 2019
 
SGC (Parent)
 
SGI (Issuer1)
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminating
Entries
 
Consolidated
Net cash (used in) provided by operating activities
$
(36
)
 
$
77

 
$
146

 
$
216

 
$

 
$
403

Cash flows from investing activities:
 

 
 

 
 

 
 

 
 

 
 
Capital expenditures
(17
)
 
(22
)
 
(85
)
 
(83
)
 

 
(207
)
Distributions of capital from equity investments

 

 

 
18

 

 
18

Additions to equity method investments

 
(1
)
 

 

 

 
(1
)
Other, principally change in intercompany investing activities

 
268

 
(61
)
 

 
(207
)
 

Net cash (used in) provided by investing activities
(17
)
 
245

 
(146
)
 
(65
)
 
(207
)
 
(190
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
 
 
Payments of long-term debt, net of proceeds

 
(306
)
 

 
(2
)
 

 
(308
)
Payments of debt issuance and deferred financing costs

 
(14
)
 

 
(1
)
 

 
(15
)
Payments on license obligations
(20
)
 
(1
)
 
(5
)
 

 

 
(26
)
Sale of future revenue

 

 
11

 

 

 
11

Net proceeds from the sale of SciPlay common stock

 

 

 
342

 

 
342

Payments of deferred SciPlay common stock offering costs

 

 

 
(9
)
 

 
(9
)
Net redemptions of common stock under stock-based compensation plans and other

 
(2
)
 
(2
)
 
(2
)
 

 
(6
)
Other, principally change in intercompany financing activities
193

 

 

 
(400
)
 
207

 

Net cash provided by (used in) financing activities
173

 
(323
)
 
4

 
(72
)
 
207

 
(11
)
Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

 

 
(1
)
 

 
(1
)
Increase (decrease) in cash, cash equivalents and restricted cash
120

 
(1
)
 
4

 
78

 

 
201

Cash, cash equivalents and restricted cash, beginning of period
74

 
2

 
44

 
101

 
(1
)
 
220

Cash, cash equivalents and restricted cash, end of period
$
194

 
$
1

 
$
48

 
$
179

 
$
(1
)
 
$
421

(1) Issuer of obligations under the Subordinated Notes, the Unsecured Notes and the Secured Notes.
SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES
SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
Nine Months Ended September 30, 2018

 
SGC (Parent)
 
SGI (Issuer1)
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminating
Entries
 
Consolidated
Net cash (used in) provided by operating activities
$
(56
)
 
$
30

 
$
153

 
$
231

 
$
(2
)
 
$
356

Cash flows from investing activities:
 

 
 

 
 

 
 

 
 

 
 
Capital expenditures
(30
)
 
(57
)
 
(122
)
 
(84
)
 

 
(293
)
Acquisitions of businesses and assets, net of cash acquired

 

 
(10
)
 
(264
)
 

 
(274
)
Distributions of capital from equity investments

 

 

 
24

 

 
24

Additions to equity method investments

 
(2
)
 

 
(74
)
 

 
(76
)
Other, principally change in intercompany investing activities

 
91

 
(15
)
 

 
(76
)
 

Net cash (used in) provided by investing activities
(30
)
 
32

 
(147
)
 
(398
)
 
(76
)
 
(619
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
 
 
Proceeds net of payments on long-term debt

 
(24
)
 

 
(6
)
 

 
(30
)
Repayment of assumed NYX debt

 

 

 
(288
)
 

 
(288
)
Payments of debt issuance and deferred financing costs

 
(39
)
 

 

 

 
(39
)
Payments on license obligations
(20
)
 

 
(2
)
 

 

 
(22
)
Net redemptions of common stock under stock-based compensation plans and other
(22
)
 

 
(2
)
 

 

 
(24
)
Other, principally change in intercompany financing activities
(565
)
 

 

 
489

 
76

 

Net cash (used in) provided by financing activities
(607
)
 
(63
)
 
(4
)
 
195

 
76

 
(403
)
Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

 

 
(2
)
 

 
(2
)
(Decrease) increase in cash, cash equivalents and restricted cash
(693
)
 
(1
)
 
2

 
26

 
(2
)
 
(668
)
Cash, cash equivalents and restricted cash, beginning of period
732

 
1

 
44

 
60

 
(3
)
 
834

Cash, cash equivalents and restricted cash end of period
$
39

 
$

 
$
46

 
$
86

 
$
(5
)
 
$
166

(1) Issuer of obligations under the Subordinated Notes, the Unsecured Notes (other than the 2026 Unsecured Notes, which were not issued until March 2019) and the Secured Notes.